RNS Number : 2606D
Legendary Investments PLC
26 April 2013
Legendary Investments PLC
("the Company")
26 April 2013
Investee Company Update
Medgold Resources Corp. ("Medgold")
Major Gold-Antimony Target Defined at Pietratonda, Italy
Legendary is pleased to report that its investee company, Medgold Resources Corp. (TSX-V: MED),
has recently completed exploration at its wholly-owned Pietratonda licence in the Colline Metallifere of Central Italy.
A total of 273 rock samples were collected (including QA-QC) and a Gold-Antimony anomaly was defined over 600 by 200 metres. The work outlines a large gold-antimony anomaly and highlights the exciting potential of the Colline Metallifere of Central Italy. Clear drill targets have been defined which are designed to test the mineralization at depth.
Zafar Karim, Executive Chairman of Legendary, said "Medgold's momentum continues to build and it remains on track towards its stated ambition to be the leading Mediterranean-focused gold exploration and project development company. We look forward to further progress."
Further details are is available at:
http://oreo.itracmediav4.com/itracEmail/view?uuid=2c0ff457-c865-4ce5-bea2-b39bafc9a586
For further information, please contact:
Contact:
|
|
|
Legendary Investments Plc
|
Zafar Karim / Thomas Reuner
|
020 8201 3536
|
Grant Thornton Corporate Finance
|
Colin Aaronson/ Melanie Frean / Jen Clarke
|
020 7383 5100
|
Simple Investments
|
Nick Emerson/ Andrew Thacker
|
01483 413500
|
Newgate Threadneedle
|
Caroline Evans-Jones
|
020 7653 9850
|
About Legendary Investments plc
Legendary is a proactive investment company that focuses on making investments in and assisting companies which exhibit the potential to generate returns of many multiples through capital appreciation. Typically, Legendary invests in small companies where there are clear catalysts for value appreciation and the companies are operating in sectors exhibiting long term growth. Examples of such sectors include technology, energy, natural resources and mining. Legendary is incorporated in the UK, which is its principal country of operation.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFSVSIIEFIV